RECRUITING

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to determine if improved risk stratification tools and interventions to mitigate malnutrition reduce postoperative risk in patients undergoing elective or emergent resection surgery for inflammatory bowel disease (IBD), and if adding immune modulation nutrition improves surgical outcomes. The primary objective is to assess whether preoperative malnutrition screening and intervention minimize postoperative complications. The secondary objective is to evaluate whether immune modulation nutrition in the peri-operative period decreases length of stay and major complications.

Official Title

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

Quick Facts

Study Start:2025-01-07
Study Completion:2027-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06309017

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Able and willing to provide written informed consent
  2. 2. Aged 18 years of age or older
  3. 3. Confirmed diagnosis of inflammatory bowel disease
  4. 4. Scheduled for disease-related intestinal resection at NYU Langone Health
  1. 1. No current diagnosis of inflammatory bowel disease
  2. 2. Age less than 18
  3. 3. Not proficient (able to read and answer questions) in English

Contacts and Locations

Study Contact

Jennifer Katz, MD
CONTACT
(855) 698-4232
Jennifer.katz@nyulangone.org

Principal Investigator

Jennifer Katz, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Jennifer Katz, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-07
Study Completion Date2027-07

Study Record Updates

Study Start Date2025-01-07
Study Completion Date2027-07

Terms related to this study

Additional Relevant MeSH Terms

  • Inflammatory Bowel Diseases